Faculty Opinions recommendation of CDK4/6 inhibitor as a novel therapeutic approach for advanced bladder cancer independently of RB1 status.
2018 ◽
Vol 25
(1)
◽
pp. 390-402
◽
2004 ◽
Vol 60
◽
pp. S376-S377
Keyword(s):
2004 ◽
Vol 60
(1)
◽
pp. S376-S377
◽
Keyword(s):
Keyword(s):
Keyword(s):